Morgan Stanley analyst Kristine Liwag named Northrop Grumman (NOC) as the firm’s Top Defense Pick, replacing L3Harris Technologies (LHX), as the firm sees the B-21 program being “significantly de-risked” after the company took a $1.2B charge as the “possible” losses on the LRIP portion of the B-21 program have now become “probable.” Yesterday’s selloff in the stock was “overdone,” argues the analyst, who views the earnings report and B-21 announcement as a “clearing event” and reiterates an Overweight rating and $579 price target on Northrop shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NOC: